Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators. (2022). Global Journal of Medical Research, 22(K2), 67-79. https://medicalresearchjournal.org/index.php/GJMR/article/view/102185